Radiotherapy–immunotherapy combinations – perspectives and challenges von Mondini, Michele, Levy, Antonin, Meziani, Lydia, Milliat, Fabien, Deutsch, Eric

Volltext

Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives von Mirghani, Haïtham, Amen, Furrat, Tao, Yungan, Deutsch, Eric, Levy, Antonin

Volltext

Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sa... von Callegaro, Dario, MD, Miceli, Rosalba, PhD, Bonvalot, Sylvie, Prof, Ferguson, Peter, MD, Strauss, Dirk C, FRCS, Levy, Antonin, MD, Griffin, Anthony, MSc, Hayes, Andrew J, FRCS, Stacchiotti, Silvia, MD, Pechoux, Cecile Le, MD, Smith, Myles J, FRCSI, Fiore, Marco, MD, Dei Tos, Angelo P, MD, Smith, Henry G, MBBS, Mariani, Luigi, PhD, Wunder, Jay S, Prof, Pollock, Raphael E, Prof, Casali, Paolo G, MD, Gronchi, Alessandro, Dr

Volltext

Can immunostimulatory agents enhance the abscopal effect of radiotherapy? von Levy, Antonin, Chargari, Cyrus, Marabelle, Aurelien, Perfettini, Jean-Luc, Magné, Nicolas, Deutsch, Eric

Volltext

Primary Extremity Soft Tissue Sarcomas: Does Local Control Impact Survival? von Bonvalot, Sylvie, Levy, Antonin, Terrier, Philippe, Tzanis, Dimitri, Bellefqih, Sara, Le Cesne, Axel, Le Péchoux, Cécile

Volltext

3364: Innovative drug-radiotherapy trials von Levy, Antonin

Volltext

Tumor Growth Rate Is an Early Indicator of Antitumor Drug Activity in Phase I Clinical Trials von FERTE, Charles, FERNANDEZ, Marianna, AMMARI, Samy, SORIA, Jean-Charles, HOLLEBECQUE, Antoine, KOSCIELNY, Serge, LEVY, Antonin, MASSARD, Christophe, BALHEDA, Rastislav, BOT, Brian, GOMEZ-ROCA, Carlos, DROMAIN, Clarisse

Volltext

Targeting a cornerstone of radiation resistance: Cancer stem cell von Moncharmont, Coralie, Levy, Antonin, Gilormini, Marion, Bertrand, Gérald, Chargari, Cyrus, Alphonse, Gersende, Ardail, Dominique, Rodriguez-Lafrasse, Claire, Magné, Nicolas

Volltext

EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease von Levy, Antonin, Hendriks, Lizza E.L., Berghmans, Thierry, Faivre-Finn, Corinne, GiajLevra, Matteo, GiajLevra, Niccolò, Hasan, Baktiar, Pochesci, Alessia, Girard, Nicolas, Greillier, Laurent, Lantuéjoul, Sylvie, Edwards, John, O'Brien, Mary, Reck, Martin, Besse, Benjamin, Novello, Silvia, Dingemans, Anne-Marie C.

Volltext

Long-term Outcomes of Oral Vinorelbine in Advanced, Progressive Desmoid Fibromatosis and Influence of CTNNB1 Mutational Status von Mir, Olivier, Honoré, Charles, Chamseddine, Ali N, Dômont, Julien, Dumont, Sarah N, Cavalcanti, Andrea, Faron, Matthieu, Rimareix, Françoise, Haddag-Miliani, Leila, Le Péchoux, Cécile, Levy, Antonin, Court, Charles, Briand, Sylvain, Fadel, Elie, Mercier, Olaf, Bayle, Arnaud, Brunet, Anaïs, Ngo, Carine, Rouleau, Etienne, Adam, Julien, Le Cesne, Axel

Volltext

KRASG12C inhibition using MRTX1257: a novel radio-sensitizing partner von Laurent, Pierre-Antoine, Milic, Marina, Quevrin, Clément, Meziani, Lydia, Liu, Winchygn, Morel, Daphné, Signolle, Nicolas, Clémenson, Céline, Levy, Antonin, Mondini, Michele, Deutsch, Eric

Volltext

Phase I Trials of Molecularly Targeted Agents: Should We Pay More Attention to Late Toxicities? von Postel-Vinay, Sophie, Gomez-Roca, Carlos, Molife, L Rhoda, Anghan, Bhavesh, Levy, Antonin, Judson, Ian, De Bono, Johann, Soria, Jean-Charles, Kaye, Stan, Paoletti, Xavier

Volltext

An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer von Levy, Antonin, Morel, Daphné, Texier, Matthieu, Sun, Roger, Durand-Labrunie, Jerome, Rodriguez-Ruiz, Maria E, Racadot, Severine, Supiot, Stéphane, Magné, Nicolas, Cyrille, Stacy, Louvel, Guillaume, Massard, Christophe, Verlingue, Loic, Bouquet, Fanny, Bustillos, Alberto, Bouarroudj, Lisa, Quevrin, Clément, Clémenson, Céline, Mondini, Michele, Meziani, Lydia, Tselikas, Lambros, Bahleda, Rastilav, Hollebecque, Antoine, Deutsch, Eric

Volltext

Eradicating gross tumor disease: a prerequisite for efficient radioimmunotherapy? von Deutsch, Eric, Levy, Antonin

Volltext

Brain Radiation Necrosis: Current Management With a Focus on Non-small Cell Lung Cancer Patients von Loganadane, Gokoulakrichenane, Dhermain, Frédéric, Louvel, Guillaume, Kauv, Paul, Deutsch, Eric, Le Péchoux, Cécile, Levy, Antonin

Volltext

Targeting head and neck cancer stem cells to overcome resistance to photon and carbon ion radiation von Bertrand, Gérald, Maalouf, Mira, Boivin, Antony, Battiston-Montagne, Priscillia, Beuve, Michael, Levy, Antonin, Jalade, Patrice, Fournier, Claudia, Ardail, Dominique, Magné, Nicolas, Alphonse, Gersende, Rodriguez-Lafrasse, Claire

Volltext

Imaging approaches and radiomics: toward a new era of ultraprecision radioimmunotherapy? von Sun, Roger, Henry, Théophraste, Laville, Adrien, Carré, Alexandre, Hamaoui, Anthony, Bockel, Sophie, Chaffai, Ines, Levy, Antonin, Chargari, Cyrus, Robert, Charlotte, Deutsch, Eric

Volltext

Immune-related arthritis following pelvic radiation therapy in a patient with lung cancer receiving long-term immune checkpoint blocker treatment: Case report von Aldea, Mihaela, Belkhir, Rakiba, Colomba, Emeline, Blanchard, Pierre, Danlos, Francois-Xavier, Botticella, Angela, Terlizzi, Mario, Deutsch, Eric, Le Péchoux, Cecile, Planchard, David, Michot, Jean-Marie, Besse, Benjamin, Levy, Antonin

Volltext

1-week hypofractionated adjuvant whole-breast radiotherapy: towards a new standard? von Levy, Antonin, Rivera, Sofia

Volltext

Current challenges of unresectable stage III NSCLC: are we ready to break the glass ceiling of the PACIFIC trial? von Remon, Jordi, Levy, Antonin, Singh, Pawan, Hendriks, Lizza E. L., Aldea, Mihaela, Arrieta, Oscar

Volltext